News

Gladstone in the News March 23, 2023

The Personalized Stem Cells That Could One Day Treat Parkinson’s and Heart Failure

The Wall Street Journal—Induced pluripotent stem cells have the potential to be used in innovative therapies for conditions like for Parkinson’s disease, macular degeneration, and heart failure. Gladstone Senior Investigator Shinya Yamanaka, who was the first to develop the technology, describes how a patient’s own cells can be used to generate tissue for transplantation.

Gladstone Experts Yamanaka Lab Stem Cells/iPSCs

Video December 1, 2022

2022 Ogawa-Yamanaka Stem Cell Prize Ceremony

Watch Juan Carlos Izpisua Belmonte present his award-winning work during the 2022 Ogawa-Yamanaka Stem Cell Prize Ceremony

Ogawa Stem Cell Prize Stem Cells/iPSCs

Article November 29, 2022

Rewinding Cells to Reverse Disease

Juan Carlos Izpisua Belmonte, recipient of the 2022 Ogawa-Yamanaka Stem Cell Prize, is turning back the clock on old and sick cells, with many potential benefits

Awards Ogawa Stem Cell Prize Profile Stem Cells/iPSCs

Article November 22, 2022

15 Years Later: This Is How Scientists Are Using Induced Pluripotent Stem Cells

Gladstone researchers talk about the power of iPS cells in biomedical research

Stem Cells/iPSCs Cardiovascular Disease Stem Cell Core

Gladstone in the News November 3, 2022

Medical Milestones Are Underway at San Francisco’s Gladstone Institutes

Nob Hill Gazette—Home to 30 labs and 500 researchers, Gladstone is a hub of cutting-edge research and advances toward cures for the most devastating diseases.

Gladstone Experts Doudna Lab Greene Lab Ott Lab Srivastava Lab Weinberger Lab Yamanaka Lab Big Data CRISPR/Gene Editing Stem Cells/iPSCs

Article June 24, 2022

The 2022 Ogawa-Yamanaka Stem Cell Prize Awarded to Juan Carlos Izpisua Belmonte

Izpisua Belmonte is recognized for his innovative work in programming cellular rejuvenation

Awards Institutional News News Release Ogawa Stem Cell Prize Stem Cells/iPSCs

Gladstone in the News March 9, 2022

Disease in a Dish: What Mini-Hearts and Other Organs Reveal about Long COVID

San Jose Mercury News—Senior Investigators Melanie Ott, MD, PhD, and Bruce Conklin, MD, recount how they used miniature balls of beating heart cells called organoids to study the effects of COVID-19 on the heart. The heart cells were derived from a person's skin cells, thanks to technology pioneered by Senior Investigator and Nobel Laureate Shinya Yamanaka, MD, PhD.

Gladstone Experts Stem Cell Core COVID-19 Cardiovascular Disease Data Science and Biotechnology Virology Conklin Lab Ott Lab Yamanaka Lab Organoids

Article February 18, 2022

Getting to the Heart of Complex Disease

Gladstone researchers develop robust strategy for sifting through large-scale genetic data to better understand congenital heart problems

News Release Research (Publication) Congenital Heart Disease Cardiovascular Disease Krogan Lab Pollard Lab Srivastava Lab Stem Cells/iPSCs

Article January 26, 2022

Mutant Stem Cells Defy Rules of Development

Removing one gene from developing heart cells suddenly makes them turn into brain cell precursors, making researchers rethink cellular identity

News Release Research (Publication) Cardiovascular Disease Bruneau Lab Stem Cells/iPSCs Hota

Article July 22, 2021

“Noisy” Gene Expression Plays Key Role in Development and May Help Improve Stem Cell Therapies

Gladstone researchers discover a fundamental mechanism that appears to speed the change of stem cells into other cell types

News Release Research (Publication) Virology Weinberger Lab Stem Cells/iPSCs Chaturvedi

Article June 21, 2021

How Do Developing Spinal Cords Choose “Heads” or “Tails”?

A new human organoid developed by Gladstone scientists mimics one of the key steps in early embryonic development

News Release Research (Publication) Cardiovascular Disease McDevitt Lab CRISPR/Gene Editing Stem Cells/iPSCs

Article April 22, 2021

Recreating the Earliest Stages of Life

Scientists generate synthetic mouse embryos containing the three fundamental cell types normally found in pre-implantation embryos

News Release Research (Publication) iPS Cell Research Center Stem Cells/iPSCs

Article April 13, 2021

World’s Largest Public ALS Data Portal Launched

Steve Finkbeiner is leading key components of this unprecedented resource to boost ALS research.

Gladstone Experts ALS Center for Systems and Therapeutics Finkbeiner Lab AI Robotic Microscopy Stem Cells/iPSCs

Video February 24, 2021

State of Stem Cell Symposium

Watch presentations from The State of Stem Cell Symposium

iPS Cell Research Center Stem Cells/iPSCs

Gladstone in the News February 3, 2021

San Francisco Researchers Use Genetic Clues to Identify Possible Drug for Treating Heart Conditions

ABC7 News—Gladstone President Deepak Srivastava, MD, a pediatric cardiologist, explains how his group discovered a potential new drug to treat a debilitating disease due to the hardening of heart valves.

Gladstone Experts Congenital Heart Disease Cardiovascular Disease Srivastava Lab Stem Cells/iPSCs